Vaccine Research in Australia: Landscaping capabilities and relevant services

Internationally, vaccines are one of the fastest growing sectors in the pharmaceutical and biotechnology industry. This project seeks to create a streamlined pathway for Australian vaccine development from the time of conception at the laboratory bench, typically in a University research lab, all the way through to human trials and commercialisation.

Whilst Australia has an exemplary record of basic immunology and vaccine research, there has been a major failure to capture the commercial value of this Australian research. This project will landscape the vaccine space, developing a free-to-use, publicly accessible database of all interested parties in the sector, and draw them together for the first Australian Vaccine conference in December 2017.

Consortium lead Vaxine
Consortium members Mylexa Pty Ltd, Australian Respiratory and Sleep Medicine Institute Ltd
MTPConnect grant $250,000
Industry contributions $250,000
Project duration March 2017 - February 2019
Contact Sharen Pringle, Vaxine -